Medios AGMEDOF 88 ROC (Joel Greenblatt) % is 24.53% as of Mar. 2026, which is 1% below its 10-year median of 24.77. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $71.50. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Medios AG ranks better than 69.49% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Medios AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 24.53%.
The historical rank and industry rank for Medios AG's ROC (Joel Greenblatt) % or its related term are showing as below:
MEDOF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -17.21 Med: 24.77 Max: 49.99
Current: 28.77
During the past 13 years, Medios AG's highest ROC (Joel Greenblatt) % was 49.99%. The lowest was -17.21%. And the median was 24.77%.
MEDOF's ROC (Joel Greenblatt) % is ranked better than 69.49% of 118
companies
in the Medical Distribution industry
Industry Median: 15.345
vs MEDOF: 28.77
Medios AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 12.90% per year.
Medios AG (OTCPK:MEDOF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Medios AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDOF vs MCK, CAH, COR: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Medios AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medios AG's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 24.53% mean?
Medios AG (MEDOF) has a ROC (Joel Greenblatt) % of 24.53% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medios AG and its competitors. This is near median its historical median of 24.77. According to the industry distribution chart, Medios AG ranks #36 out of 118 companies in the Medical Distribution industry, placing it in the top 30.5%.
Is Medios AG's ROC (Joel Greenblatt) % too high?
Medios AG's current ROC (Joel Greenblatt) % of 24.53% is near median its 10-year median of 24.77. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.35. Medios AG's value of 24.53% is 59.9% above this industry median. Based on the distribution chart, Medios AG ranks #36 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's ROC (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #36 out of 118 companies for ROC (Joel Greenblatt) %. This puts Medios AG in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 15.35. Medios AG's value of 24.53% is 59.9% above this benchmark. While the company's 10-year median is 24.77 vs. the industry median of 15.35, Medios AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.35, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current ROC (Joel Greenblatt) % of 24.53% is 59.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current ROC (Joel Greenblatt) % is 24.53%, which is near median its own 10-year median of 24.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current ROC (Joel Greenblatt) % of 24.53%. The stock's GF Value™ is $71.50, compared to a current price of $50.00 — trading 30.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 24.53%, which is near median its 10-year median of 24.77 and 59.9% above the Medical Distribution industry median of 15.35. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Medios AG (MEDOF), the current ROC (Joel Greenblatt) % is 24.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.
Key valuation signals for MEDOF:
ROC (Joel Greenblatt) %: 24.53% (near median its 10-year median of 24.77)
GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
Industry Position: 59.9% above the Medical Distribution median (#36 of 118)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
